Objective: As the pandemic spreads worldwide, individuals are exposed to factors such as social isolation, economic uncertainty, and general stress, which has increased the risk of substance use and addiction. Studies show that the SARS-CoV-2 (COVID-19) pandemic has increased substance use disorders. The aim of this study is to examine the impact of the COVID-19 pandemic on substance use disorders.Method: The study was planned as a retrospective study. This study was based on March 11, 2020, the date when the COVID-19 case was first seen in Turkey, for 4 years, including two years before the pandemic and two years during the pandemic process, between 11.03.2018 and 11.03.2022. 1743 cases referred to the psychiatric outpatient clinic within the scope of probation were included.Results: While substance use was detected in 834 people in the pre-COVID-19 pandemic period (March 2018-March 2020), substance use was detected in 909 people during the COVID-19 pandemic period (March 2020-March 2022). A significant increase in substance use was detected in female gender during the pandemic period. A statistically significant increase was observed in methamphetamine, opioid, cocaine and multiple substance use during the pandemic period compared to the pre-pandemic period.Conclusion: The data of our study show substance use rates in Turkey before and during the pandemic. The study will be useful to understand the impact of COVID-19 on drug use frequencies in Türkiye.
24 January 2026 in Anadolu Kliniği Tıp Bilimleri Dergisi
Aim: This study was conducted to investigate the effects of depression and anxiety on sleep quality in patients receiving hemodialysis treatment and to evaluate these relationships. Methods: The study was conducted in a cross-sectional design in a training and research hospital in Turkey. The study included 101 hemodialysis patients and 100 healthy control participants. The sample size was calculated using G*Power software (effect size = 0.48; α = 0.05; power = 0.95); requiring a minimum of 180 participants. Hospital Anxiety and Depression Scale (HADS); Pittsburgh Sleep Quality Index (PSQI); Insomnia Severity Index (ISI); and Epworth Sleepiness Scale (ESS) were used as data collection tools. Independent samples t-tests and Pearson correlations were used for group comparisons and associations. Multiple linear regression was employed to identify predictors of sleep quality. Results: Depression and anxiety scores were significantly higher in the hemodialysis group compared to the control group (p
1 June 2026 in Journal of Clinical and Analytical Medicine
Introduction Glycated haemoglobin (HbA1c) is an essential biomarker for assessing glycaemic control in diabetes mellitus. However, haemoglobin variants can interfere with the accuracy of HbA1c measurements. Case Presentation This case describes a 34-year-old man with beta-thalassemia trait in whom standard HbA1c testing gave misleading results. Despite normal glucose and insulin levels, HbA1c testing by HPLC revealed an unexpectedly low value of 3.1%, which was confirmed on reanalysis. Further testing identified the Hb J Bangkok variant, which was confirmed by genetic testing. Conclusion This case highlights the importance of considering haemoglobin variants such as Hb J Bangkok when interpreting HbA1c results, as these variants can lead to significant discrepancies in glycaemic assessment and misdiagnosis. In such scenarios, comprehensive genetic evaluation is essential to ensure accurate diagnosis and appropriate patient management.